How to use Sinarest (levosalbutamol) Vapocap?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Use Sinarest (Levosalbutamol) Vapocap

I cannot provide specific usage instructions for "Sinarest Vapocap" as this exact product formulation is not described in the available medical literature or guidelines provided.

What the Evidence Shows About Levosalbutamol

Levosalbutamol is the therapeutically active R-isomer of salbutamol, a beta-2 agonist bronchodilator used for treating bronchospasm in asthma, COPD, and other respiratory conditions. 1

Standard Levosalbutamol Formulations and Dosing

The available evidence describes levosalbutamol in these forms:

  • Nebulizer solution: 0.63 mg/3 mL or 1.25 mg/3 mL preparations 2
  • Oral solutions/syrups: Combination products containing levosalbutamol with mucolytics and expectorants 3, 4
  • Inhaled formulations: For acute asthma exacerbations 2

Typical Levosalbutamol Dosing Patterns

For acute bronchospasm (nebulized):

  • Children: 0.075 mg/kg (minimum 1.25 mg) every 20 minutes for 3 doses, then 0.075-0.15 mg/kg every 1-4 hours as needed 2
  • Adults: 0.25-2.5 mg every 20 minutes for 3 doses, then 5 mg every 1-4 hours as needed 2

For oral combination products (cough formulations):

  • Typically 10 mL three times daily in adults with productive cough 4
  • Used commonly for lower respiratory tract infections, acute exacerbations of chronic bronchitis, and bronchial asthma 3

Critical Safety Considerations

  • Levosalbutamol is generally well tolerated with side effects including tremor (1%), palpitations (0.9%), and vomiting (0.7%) that are typically mild and transient 3
  • The risk/benefit ratio of levosalbutamol is reported to be superior to racemic salbutamol because it eliminates the potentially harmful S-enantiomer 5
  • Levosalbutamol 0.625 mg is at least as effective as racemic salbutamol 2.5 mg for symptom relief 5

What You Should Do

Contact the prescribing physician or pharmacist for specific instructions on your "Sinarest Vapocap" product, as:

  • The exact formulation, strength, and delivery method are not standardized across products
  • Dosing depends on the specific concentration and whether it's for nebulization, oral use, or another route
  • Age, weight, and specific respiratory condition determine appropriate dosing

If this is an inhalation capsule (suggested by "Vapocap" name), it likely requires a specific inhaler device - confirm the proper technique and device compatibility with your healthcare provider before use.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.